arthyperАртериальная гипертензия"Arterial’naya Gipertenziya" ("Arterial Hypertension")1607-419X2411-8524Antihypertensive League10.18705/1607-419X-2018-24-5-586-595arthyper-1757Research ArticleОРИГИНАЛЬНАЯ СТАТЬЯORIGINAL ARTICLEФиксированная комбинация амлодипина и индапамида-ретард в лечении неконтролируемой артериальной гипертонии у лиц старше 55 летFixed combination of amlodipine/indapamide-retard in the treatment of uncontrolled hypertension in subjects over 55 years oldКобалаваЖ. Д.KobalavaZh. D.

Кобалава Жанна Давидовна — доктор медицинских наук, профессор, заведующая кафедрой пропедевтики внутренних болезней РУДН.

 

Zhanna D. Kobalava, MD, PhD, DSc, Professor, Head, Department of Propedeutics of Internal Diseases.

61 Vavilov street, Moscow,  117292.

zkobalava@mail.ruШавароваЕ. К.ShavarovaE. K.

Шаварова Елена Курбановна — кандидат медицинских наук, доцент кафедры внутренних болезней с курсом кардиологии и функциональной диагностики РУДН.

ул. Вавилова, д. 61, Москва, 117292.

Elena K. Shavarova, MD, PhD, Associate Professor, Department of Internal Diseases with the Course of Cardiology and Functional Diagnostics.

61 Vavilov street, Moscow,  117292.

ХомоваИ. А.ChomovaI. A.

Хомова Ирина Александровна — клинический ординатор кафедры внутренних болезней с курсом кардиологии и функциональной диагностики РУДН.

ул. Вавилова, д. 61, Москва, 117292.

Irina A. Chomova — MD, Resident, Internal Diseases Department.

61 Vavilov street, Moscow,  117292.

ГореваЛ. А.GorevaL. A.

Горева Любовь Анатольевна — кандидат медицинских наук, ассистент кафедры внутренних болезней с курсом кардиологии и функциональной диагностики РУДН.

ул. Вавилова, д. 61, Москва, 117292.

Lubov A. Goreva, MD, PhD, Assistant Professor, Department of Internal Diseases with the Course of Cardiology and Functional Diagnostics.

61 Vavilov street, Moscow,  117292.

КарапетянЛ. В.Karapetyan,L. V.

Карапетян Лала Вазгеновна — кандидат медицинских наук, доцент кафедры внутренних болезней с курсом кардиологии и функциональной диагностики РУДН.

ул. Вавилова, д. 61, Москва, 117292.

Lala V. Karapetyan, MD, PhD, Associate Professor,  Department of Internal Diseases with the Course of Cardiology and Functional Diagnostics.

61 Vavilov street, Moscow,  117292.

Федеральное государственное автономное образовательное  учреждение высшего образования «Российский университет  дружбы народов» (РУДН).РоссияPeoples’ Friendship University of Russia.Russian Federation201822112018245586595Copyright © Кобалава Ж.Д., Шаварова Е.К., Хомова И.А., Горева Л.А., Карапетян Л.В., 20182018Кобалава Ж.Д., Шаварова Е.К., Хомова И.А., Горева Л.А., Карапетян Л.В.Kobalava Z.D., Shavarova E.K., Chomova I.A., Goreva L.A., Karapetyan, L.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://htn.almazovcentre.ru/jour/article/view/1757амлодипининдапамид-ретардантигипертензивная эффективностьбезопасностьamlodipineindapamide-retardantihypertensive efficacysafetyReferencesШальнова С. А., Деев А. Д., Оганов Р. Г., Шестов Д. Б. Роль систолического и диастолического артериального давления для прогноза смертности от сердечно-сосудистых заболеваний. Кардиоваскулярная терапия и профилактика. 2002;1:10–15. [Shalnova SA, Deev AD, Oganov RG, Shestov DB. The prognostic role of systolic and diastolic blood pressure for cardiovascular morbidity. Kardiovaskulyarnaya Terapiya i Profilaktika = Cardiovascular Therapy and Prevention. 2002;1:10–15 In Russian].Шальнова С. А., Деев А. Д., Оганов Р. Г., Шестов Д. Б. Роль систолического и диастолического артериального давления для прогноза смертности от сердечно-сосудистых заболеваний. Кардиоваскулярная терапия и профилактика. 2002;1:10–15. [Shalnova SA, Deev AD, Oganov RG, Shestov DB. The prognostic role of systolic and diastolic blood pressure for cardiovascular morbidity. Kardiovaskulyarnaya Terapiya i Profilaktika = Cardiovascular Therapy and Prevention. 2002;1:10–15 In Russian].Моисеев В. С., Кобалава Ж. Д. АРГУС: артериальная гипертония у лиц старших возрастных групп. М.: МИА, 2002. 448 с. [Moiseev VS, Kobalava ZhD. ARGUS: hypertension in elderly patients. M.: MIA, 2002. 448 p. In Russian].Моисеев В. С., Кобалава Ж. Д. АРГУС: артериальная гипертония у лиц старших возрастных групп. М.: МИА, 2002. 448 с. [Moiseev VS, Kobalava ZhD. ARGUS: hypertension in elderly patients. M.: MIA, 2002. 448 p. In Russian].Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhäger WH et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet. 1997;350(9080):757–764.Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhäger WH et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet. 1997;350(9080):757–764.Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. J Am Med Assoc. 1991;265 (24):3255–3264.Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. J Am Med Assoc. 1991;265 (24):3255–3264.Lindholm LH, Hansson L, Dahlöf B, Ekbom T, Hedner T, De Faire U et al. The Swedish Trial in old patients with hypertension-2 (STOP-hypertension-2): a progress report. Blood Press. 1996;5 (5):300–304.Lindholm LH, Hansson L, Dahlöf B, Ekbom T, Hedner T, De Faire U et al. The Swedish Trial in old patients with hypertension-2 (STOP-hypertension-2): a progress report. Blood Press. 1996;5 (5):300–304.Agnoletti D, Zhang Yi, Borghi C, Blacher J, Safar ME. Effects of antihypertensive drugs on central blood pressure in humans: a preliminary observation. Am J Hypertens. 2013;26 (8):1045–1052.Agnoletti D, Zhang Yi, Borghi C, Blacher J, Safar ME. Effects of antihypertensive drugs on central blood pressure in humans: a preliminary observation. Am J Hypertens. 2013;26 (8):1045–1052.Rimoldi SF, Messerli FH, Chavez P, Stefanini GG, Scherrer U et al. Efficacy and safety of calcium channel blocker/diuretics combination therapy in hypertensive patients: a meta-analysis. J Clin Hypertens. 2015;17(3):193–199.Rimoldi SF, Messerli FH, Chavez P, Stefanini GG, Scherrer U et al. Efficacy and safety of calcium channel blocker/diuretics combination therapy in hypertensive patients: a meta-analysis. J Clin Hypertens. 2015;17(3):193–199.Aronow WS, Fleg JL, Pepine CJ, Artinian NT, Bakris G, Brown AS et al. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation. 2011;123(21):2434–2506.Aronow WS, Fleg JL, Pepine CJ, Artinian NT, Bakris G, Brown AS et al. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation. 2011;123(21):2434–2506.2018 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH/ESC Task Force for the management of arterial hypertenion. J Hypertens. 2018;36 (12):2284–2309. doi:10.1097/HJH.00000000000019612018 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH/ESC Task Force for the management of arterial hypertenion. J Hypertens. 2018;36 (12):2284–2309. doi:10.1097/HJH.0000000000001961ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in highrisk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288(23):2981–2997.ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in highrisk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288(23):2981–2997.Liu L, Wang JG, Gong L, Liu G, Staessen JA. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group. J Hypertens. 1998;16(12 Pt 1): 1823.Liu L, Wang JG, Gong L, Liu G, Staessen JA. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group. J Hypertens. 1998;16(12 Pt 1): 1823.Jamerson K, Weber MA, Bakris GL, Dahlöf B, Pitt B, Shi V et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359(23): 2417–2428.Jamerson K, Weber MA, Bakris GL, Dahlöf B, Pitt B, Shi V et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359(23): 2417–2428.Baguet JP, Legallicier B, Auquier P, Robitail S. Updated meta-analytical approach to efficacy of antihypertensive drugs in reducing blood pressure. Clinical Drug Invest. 2007;27(11):735– 753.Baguet JP, Legallicier B, Auquier P, Robitail S. Updated meta-analytical approach to efficacy of antihypertensive drugs in reducing blood pressure. Clinical Drug Invest. 2007;27(11):735– 753.Кобалава Ж. Д., Шаварова Е. К. Клинические особенности артериальной гипертонии в пожилом и старческом возрасте и обоснование применения комбинации амлодипин/индапамид ретард. Кардиология. 2017;57(8):60–70. [Kobalava ZhD, Shavarova EK. Clinical features of arterial hypertension in the elderly and senile age and the rationale for using the combination of amlodipine/indapamide-retard. Kardiologiia. 2017;57(8):60–70. In Russian].Кобалава Ж. Д., Шаварова Е. К. Клинические особенности артериальной гипертонии в пожилом и старческом возрасте и обоснование применения комбинации амлодипин/индапамид ретард. Кардиология. 2017;57(8):60–70. [Kobalava ZhD, Shavarova EK. Clinical features of arterial hypertension in the elderly and senile age and the rationale for using the combination of amlodipine/indapamide-retard. Kardiologiia. 2017;57(8):60–70. In Russian].Alderman MH, Cohen HW, Sealey JE, Laragh JH. Pressor responses to antihypertensive drug types. Am J Hypertens. 2010;23 (9):1033–1037.Alderman MH, Cohen HW, Sealey JE, Laragh JH. Pressor responses to antihypertensive drug types. Am J Hypertens. 2010;23 (9):1033–1037.Furberg CD. Renin-guided treatment of hypertension: time for action. Am J Hypertens. 2010;23(9):929–930.Furberg CD. Renin-guided treatment of hypertension: time for action. Am J Hypertens. 2010;23(9):929–930.Brown MJ. Heterogeneity of blood pressure response to therapy. Am J Hypertens. 2010;23(9):926–928.Brown MJ. Heterogeneity of blood pressure response to therapy. Am J Hypertens. 2010;23(9):926–928.Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D et al. on behalf the CAFÉ Investigators. Differential impact of blood pressure — lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation. 2006;113(9):1213–1225.Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D et al. on behalf the CAFÉ Investigators. Differential impact of blood pressure — lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation. 2006;113(9):1213–1225.Cecelja M, Chowienczyk P. Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension: a systematic review. Hypertension. 2009;54(6): 1328–1336.Cecelja M, Chowienczyk P. Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension: a systematic review. Hypertension. 2009;54(6): 1328–1336.Burke GL, Bertoni AG, Shea S, Tracy R, Watson KE, Blumenthal RS, et al. The impact of obesity on cardiovascular disease risk factors and subclinical vascular disease: the MultiEthnic Study of Atherosclerosis. Arch Intern Med. 2008;168 (9):928–935.Burke GL, Bertoni AG, Shea S, Tracy R, Watson KE, Blumenthal RS, et al. The impact of obesity on cardiovascular disease risk factors and subclinical vascular disease: the MultiEthnic Study of Atherosclerosis. Arch Intern Med. 2008;168 (9):928–935.Mitchell GF, Hwang S-J, Vasan RS, Larson MG, Pencina MJ, Hamburg NM et al. Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation. 2010;121(4):505–511.Mitchell GF, Hwang S-J, Vasan RS, Larson MG, Pencina MJ, Hamburg NM et al. Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation. 2010;121(4):505–511.

The authors declare that there are no conflicts of interest present.